NCT06321939View on ClinicalTrials.gov

Sequencing-based Counting of Plasma Epstein-Barr Virus DNA in Non-metastatic Nasopharyngeal Carcinoma

RecruitingOBSERVATIONAL

Enrollment

50

Participants

Timeline

Start Date

January 11, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2028

Conditions

Nasopharyngeal CarcinomaHerpesvirus 4, Human

Interventions

DIAGNOSTIC_TEST

EBV-DNA next generation sequencing

EBV-DNA next generation sequencing

Trial Locations (1)

Unknown

RECRUITING

Hunan cancer Hospital, Changsha

All Listed Sponsors

lead

Hunan Cancer Hospital

OTHER